SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe
July 24, 2023 07:30 ET
|
SomaLogic
BOULDER, Colo. and L’AQUILA, Italy, July 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with...
SomaLogic Partners with Citogen to Expand Authorized Site Program in Europe
June 12, 2023 09:00 ET
|
SomaLogic
BOULDER, Colo., June 12, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today their collaboration with Citogen, the Longwood Group’s customer services and...
SomaLogic Announces Chief Financial Officer Transition
June 06, 2023 16:05 ET
|
SomaLogic
Appoints Eliot M. Lurier, CPA, as Interim Chief Financial Officer Reaffirms 2023 Financial Guidance BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc. (Nasdaq: SLGC), a leader...
SomaLogic to Participate in the Jefferies Healthcare Conference
May 24, 2023 16:30 ET
|
SomaLogic
BOULDER, Colo., May 24, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that the company will be participating in the upcoming Jefferies Healthcare...
SomaLogic Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET
|
SomaLogic
First quarter 2023 revenue of $20.4 million, representing a decrease of 11% year-over-year; excluding licensing, revenue increased 2% year-over-yearReiterating full year 2023 revenue guidance of...
SomaLogic expands into China with groundbreaking Biostar Technology Limited Partnership
May 10, 2023 09:00 ET
|
SomaLogic
SHANGHAI and BOULDER, Colo., May 10, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, announced today that Biostar Technology Limited will be the company’s first...
SomaLogic opens their first-ever proteomics grant program to APAC life sciences researchers
May 07, 2023 21:00 ET
|
SomaLogic
Two winners will be awarded 40 human plasma or serum samples to be processed on the SomaScan® Platform at Genomax’s Singapore lab SINGAPORE & BOULDER, Colo., May 07, 2023 (GLOBE NEWSWIRE) --...
SomaLogic to Announce First Quarter 2023 Financial Results on May 11, 2023
April 20, 2023 16:30 ET
|
SomaLogic
BOULDER, Colo., April 20, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market...
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution
March 28, 2023 16:05 ET
|
SomaLogic
Adam Taich, EVP Life Sciences, promoted to interim CEO with a focus on operational executionBoard transition adds industry veterans: Jason Ryan as Chairman; Tycho Peterson, Kathy Hibbs, and Tom Carey...
Oxford Population Health and SomaLogic deliver 28 million proteomic data points on China Kadoorie Biobank samples
March 13, 2023 08:00 ET
|
SomaLogic
BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the...